Another dopamine receptor agonist, cabergoline decreased waist circumference, plasma lipids, glycated haemoglobin, insulin and the homeostatic model assessment of insulin resistance (HOMA-IR) and this effect, observed regardless of the degree of reduction in prolactin levels, was dose-dependent [10]. The gene discussed is PRL; the disease is Insulin resistance.